IL141680A0 - Use of 3-(1h-imidazol--4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration - Google Patents
Use of 3-(1h-imidazol--4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administrationInfo
- Publication number
- IL141680A0 IL141680A0 IL14168099A IL14168099A IL141680A0 IL 141680 A0 IL141680 A0 IL 141680A0 IL 14168099 A IL14168099 A IL 14168099A IL 14168099 A IL14168099 A IL 14168099A IL 141680 A0 IL141680 A0 IL 141680A0
- Authority
- IL
- Israel
- Prior art keywords
- indan
- imidazol
- ylmethyl
- intraspinal
- intrathecal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10198698P | 1998-09-28 | 1998-09-28 | |
PCT/FI1999/000793 WO2000018400A1 (en) | 1998-09-28 | 1999-09-27 | Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration |
Publications (1)
Publication Number | Publication Date |
---|---|
IL141680A0 true IL141680A0 (en) | 2002-03-10 |
Family
ID=22287519
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14168099A IL141680A0 (en) | 1998-09-28 | 1999-09-27 | Use of 3-(1h-imidazol--4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration |
IL141680A IL141680A (en) | 1998-09-28 | 2001-02-27 | Use of 3 - (H1 - imidazole - 4 - ilmethyl) - indan - 5 - all in the manufacture of a drug for intramuscular, intracranial or epidural administration |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL141680A IL141680A (en) | 1998-09-28 | 2001-02-27 | Use of 3 - (H1 - imidazole - 4 - ilmethyl) - indan - 5 - all in the manufacture of a drug for intramuscular, intracranial or epidural administration |
Country Status (24)
Country | Link |
---|---|
US (1) | US6495584B1 (ru) |
EP (1) | EP1117399B1 (ru) |
JP (1) | JP4647785B2 (ru) |
KR (1) | KR100646811B1 (ru) |
CN (1) | CN1320034A (ru) |
AT (1) | ATE288753T1 (ru) |
AU (1) | AU756104B2 (ru) |
BG (1) | BG105469A (ru) |
CA (1) | CA2345521C (ru) |
CZ (1) | CZ299918B6 (ru) |
DE (1) | DE69923698T2 (ru) |
DK (1) | DK1117399T3 (ru) |
EA (1) | EA003216B1 (ru) |
EE (1) | EE200100193A (ru) |
ES (1) | ES2237205T3 (ru) |
HK (1) | HK1039751A1 (ru) |
HU (1) | HU227634B1 (ru) |
IL (2) | IL141680A0 (ru) |
NO (1) | NO330436B1 (ru) |
NZ (1) | NZ510233A (ru) |
PL (1) | PL346908A1 (ru) |
SK (1) | SK3812001A3 (ru) |
UA (1) | UA61152C2 (ru) |
WO (1) | WO2000018400A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001000192A2 (en) * | 1999-06-25 | 2001-01-04 | Orion Corporation | Method of administering an imidazole derivative to obtain analgesia |
FI20022159A0 (fi) | 2002-12-05 | 2002-12-05 | Orion Corp | Uusia farmaseuttisia yhdisteitä |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI894911A0 (fi) * | 1989-10-17 | 1989-10-17 | Farmos Oy | En terapeutiskt vaerdefull foerening. |
GB9520150D0 (en) * | 1995-10-03 | 1995-12-06 | Orion Yhtymae Oy | New imidazole derivatives |
US5801188A (en) * | 1997-01-08 | 1998-09-01 | Medtronic Inc. | Clonidine therapy enhancement |
-
1999
- 1999-09-27 EP EP99969677A patent/EP1117399B1/en not_active Expired - Lifetime
- 1999-09-27 US US09/787,886 patent/US6495584B1/en not_active Expired - Lifetime
- 1999-09-27 CN CN99811480A patent/CN1320034A/zh active Pending
- 1999-09-27 HU HU0103864A patent/HU227634B1/hu unknown
- 1999-09-27 ES ES99969677T patent/ES2237205T3/es not_active Expired - Lifetime
- 1999-09-27 UA UA2001042926A patent/UA61152C2/uk unknown
- 1999-09-27 WO PCT/FI1999/000793 patent/WO2000018400A1/en active IP Right Grant
- 1999-09-27 CA CA002345521A patent/CA2345521C/en not_active Expired - Lifetime
- 1999-09-27 PL PL99346908A patent/PL346908A1/xx not_active Application Discontinuation
- 1999-09-27 JP JP2000571918A patent/JP4647785B2/ja not_active Expired - Lifetime
- 1999-09-27 AT AT99969677T patent/ATE288753T1/de not_active IP Right Cessation
- 1999-09-27 DE DE69923698T patent/DE69923698T2/de not_active Expired - Lifetime
- 1999-09-27 EA EA200100405A patent/EA003216B1/ru not_active IP Right Cessation
- 1999-09-27 SK SK381-2001A patent/SK3812001A3/sk unknown
- 1999-09-27 AU AU59860/99A patent/AU756104B2/en not_active Expired
- 1999-09-27 EE EEP200100193A patent/EE200100193A/xx unknown
- 1999-09-27 NZ NZ510233A patent/NZ510233A/en not_active IP Right Cessation
- 1999-09-27 CZ CZ20010933A patent/CZ299918B6/cs not_active IP Right Cessation
- 1999-09-27 DK DK99969677T patent/DK1117399T3/da active
- 1999-09-27 KR KR1020017003511A patent/KR100646811B1/ko active IP Right Grant
- 1999-09-27 IL IL14168099A patent/IL141680A0/xx active IP Right Grant
-
2001
- 2001-02-27 IL IL141680A patent/IL141680A/en not_active IP Right Cessation
- 2001-03-26 NO NO20011545A patent/NO330436B1/no not_active IP Right Cessation
- 2001-04-25 BG BG105469A patent/BG105469A/xx unknown
-
2002
- 2002-02-22 HK HK02101329.8A patent/HK1039751A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Patel et al. | Remifentanil | |
JPH06157301A (ja) | トラマドール物質及び非ステロイド抗炎症薬を含んで成る組成物 | |
JP2006213736A (ja) | 鎮痛剤およびその使用 | |
EE200300106A (et) | Farmatseutiline kompositsioon kui süsteemne analgeetikum | |
CY1111088T1 (el) | Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση | |
MX2007006637A (es) | Uso de atazanavir para mejorar los parametros farmacocineticos de farmacos metabolizados por isoforma 1a1 de udp-glucuronosil- transferasa. | |
WO2006050002A3 (en) | Compositions for controlled delivery of pharmaceutically active compounds | |
WO2003105830A1 (ja) | 脳機能を改善する医薬組成物および脳機能を改善するための方法 | |
EP1177791A3 (en) | Use of glycogen phosphorylase inhibitors to inhibit tumor growth | |
ATE279192T1 (de) | Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugung | |
WO1994016689A1 (en) | Analgesic medicinal composition | |
NO20031410L (no) | Anvendelse av distamycinderivater for fremstilling av medikamenter | |
JPS59206309A (ja) | 急発作障害の処置及びそれに有用な製薬組成物 | |
IL141680A0 (en) | Use of 3-(1h-imidazol--4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration | |
BG106180A (en) | Pharmaceutical composition containing sibutramine and orlistat | |
WO2005065372A3 (en) | Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseases | |
MXPA04010658A (es) | Tratamiento de dolor con ifenprodil. | |
WO2001000192A3 (en) | Method of administering an imidazole derivative to obtain analgesia | |
Bruhn | ESRA19-0716 Pain rebound in day surgery: how can we avoid it? | |
Luthra et al. | Intravenous Anesthetic Agents | |
JP6714225B2 (ja) | 肝細胞癌の予防又は治療のための医薬 | |
MXPA02007454A (es) | Compuestos utiles para tratamiento o prevencion de una enfermedad mediada por el alfa-2b-adrenoceptor. | |
US20070043111A1 (en) | Use of ifenprodril in the treatment of pain | |
Rorarius et al. | The effect of diclofenac and ketoprofen on halothane MAC in rabbit | |
JPS646169B2 (ru) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted |